Copyright Reports & Markets. All rights reserved.

Global Genetic Modification Therapies Market Growth (Status and Outlook) 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Genetic Modification Therapies Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Genetic Modification Therapies Market Size 2014-2024
        • 2.1.2 Genetic Modification Therapies Market Size CAGR by Region
      • 2.2 Genetic Modification Therapies Segment by Type
        • 2.2.1 Gene Therapies
        • 2.2.2 Genetically Modified Cell Therapies
        • 2.2.3 RNA Therapies
        • 2.2.4 Gene Editing
      • 2.3 Genetic Modification Therapies Market Size by Type
        • 2.3.1 Global Genetic Modification Therapies Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Genetic Modification Therapies Market Size Growth Rate by Type (2014-2019)
      • 2.4 Genetic Modification Therapies Segment by Application
        • 2.4.1 Hospitals
        • 2.4.2 Diagnostics and Testing Laboratories
        • 2.4.3 Academic and Research Organizations
        • 2.4.4 Others
      • 2.5 Genetic Modification Therapies Market Size by Application
        • 2.5.1 Global Genetic Modification Therapies Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Genetic Modification Therapies Market Size Growth Rate by Application (2014-2019)

      3 Global Genetic Modification Therapies by Players

      • 3.1 Global Genetic Modification Therapies Market Size Market Share by Players
        • 3.1.1 Global Genetic Modification Therapies Market Size by Players (2017-2019)
        • 3.1.2 Global Genetic Modification Therapies Market Size Market Share by Players (2017-2019)
      • 3.2 Global Genetic Modification Therapies Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Genetic Modification Therapies by Regions

      • 4.1 Genetic Modification Therapies Market Size by Regions
      • 4.2 Americas Genetic Modification Therapies Market Size Growth
      • 4.3 APAC Genetic Modification Therapies Market Size Growth
      • 4.4 Europe Genetic Modification Therapies Market Size Growth
      • 4.5 Middle East & Africa Genetic Modification Therapies Market Size Growth

      5 Americas

      • 5.1 Americas Genetic Modification Therapies Market Size by Countries
      • 5.2 Americas Genetic Modification Therapies Market Size by Type
      • 5.3 Americas Genetic Modification Therapies Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Genetic Modification Therapies Market Size by Countries
      • 6.2 APAC Genetic Modification Therapies Market Size by Type
      • 6.3 APAC Genetic Modification Therapies Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Genetic Modification Therapies by Countries
      • 7.2 Europe Genetic Modification Therapies Market Size by Type
      • 7.3 Europe Genetic Modification Therapies Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Genetic Modification Therapies by Countries
      • 8.2 Middle East & Africa Genetic Modification Therapies Market Size by Type
      • 8.3 Middle East & Africa Genetic Modification Therapies Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Genetic Modification Therapies Market Forecast

      • 10.1 Global Genetic Modification Therapies Market Size Forecast (2019-2024)
      • 10.2 Global Genetic Modification Therapies Forecast by Regions
        • 10.2.1 Global Genetic Modification Therapies Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Genetic Modification Therapies Forecast by Type
      • 10.8 Global Genetic Modification Therapies Forecast by Application

      11 Key Players Analysis

      • 11.1 4D Molecular Therapeutics
        • 11.1.1 Company Details
        • 11.1.2 Genetic Modification Therapies Product Offered
        • 11.1.3 4D Molecular Therapeutics Genetic Modification Therapies Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 4D Molecular Therapeutics News
      • 11.2 Abeona Therapeutics
        • 11.2.1 Company Details
        • 11.2.2 Genetic Modification Therapies Product Offered
        • 11.2.3 Abeona Therapeutics Genetic Modification Therapies Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Abeona Therapeutics News
      • 11.3 Allergan
        • 11.3.1 Company Details
        • 11.3.2 Genetic Modification Therapies Product Offered
        • 11.3.3 Allergan Genetic Modification Therapies Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Allergan News
      • 11.4 American Gene Technologies
        • 11.4.1 Company Details
        • 11.4.2 Genetic Modification Therapies Product Offered
        • 11.4.3 American Gene Technologies Genetic Modification Therapies Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 American Gene Technologies News
      • 11.5 Merck Millipore
        • 11.5.1 Company Details
        • 11.5.2 Genetic Modification Therapies Product Offered
        • 11.5.3 Merck Millipore Genetic Modification Therapies Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Merck Millipore News
      • 11.6 AbbVie
        • 11.6.1 Company Details
        • 11.6.2 Genetic Modification Therapies Product Offered
        • 11.6.3 AbbVie Genetic Modification Therapies Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 AbbVie News

      ...

        12 Research Findings and Conclusion

        Genetic modification of humans via gene therapy is becoming a treatment option for diseases ranging from rare metabolic disorders to cancer.

        According to this study, over the next five years the Genetic Modification Therapies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Genetic Modification Therapies business, shared in Chapter 3.

        This report presents a comprehensive overview, market shares and growth opportunities of Genetic Modification Therapies market by product type, application, key companies and key regions.

        This study considers the Genetic Modification Therapies value generated from the sales of the following segments:

        Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
        Gene Therapies
        Genetically Modified Cell Therapies
        Gene Editing
        Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
        Hospitals
        Diagnostics and Testing Laboratories
        Academic and Research Organizations
        Others

        This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
        Americas
        United States
        Canada
        Mexico
        Brazil
        APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

        The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
        4D Molecular Therapeutics
        Abeona Therapeutics
        Allergan
        American Gene Technologies
        Merck Millipore
        AbbVie
        ...

        In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

        Research objectives
        To study and analyze the global Genetic Modification Therapies market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
        To understand the structure of Genetic Modification Therapies market by identifying its various subsegments.
        Focuses on the key global Genetic Modification Therapies players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
        To analyze the Genetic Modification Therapies with respect to individual growth trends, future prospects, and their contribution to the total market.
        To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
        To project the size of Genetic Modification Therapies submarkets, with respect to key regions (along with their respective key countries).
        To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        Buy now